Hims & Hers Health Inc. has announced a new offer allowing eligible new customers to access a 6-month supply of Wegovy®, a prescription medication for obesity care, at a reduced price of $549 per month. This limited-time offer is part of the company's commitment to making obesity treatments more affordable and accessible to millions of Americans. The package includes access to Hims & Hers' holistic approach to weight loss, which incorporates technology-driven solutions and a variety of weight loss treatment options. CEO and co-founder Andrew Dudum emphasized the company's dedication to increasing access to essential health care services.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。